Skip to main content
Clinical Trials/NCT04145973
NCT04145973
Recruiting
Not Applicable

Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery Via Analysis of Immunoinflammation-related Protein Complexes in Blood

Peking Union Medical College Hospital1 site in 1 country200 target enrollmentStarted: April 1, 2019Last updated:
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
200
Locations
1
Primary Endpoint
blood markers

Overview

Brief Summary

The relationship between immune inflammation-related protein complexes in blood and recurrence or metastasis of breast cancer with completed standard treatment will be studied.

Detailed Description

200 patients with breast cancer and recurrence or metastasis after surgery will be followed up. Peripheral venous blood was collected every 3 to 6 months. Change regularity of breast cancer-specific immune inflammation-related protein complexes in blood at different follow-up time points will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
36 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • invasive breast cancer patients confirmed by postoperative pathology after surgery for breast lump
  • Breast cancer-related chemotherapy and radiotherapy completed
  • breast cancer patients with recurrence and metastasis after surgery

Exclusion Criteria

  • Aged above 60
  • Breast Carcinoma in situ
  • Women in pregnancy or breastfeeding
  • Suffering from other malignant tumors
  • Non-compliant patient

Outcomes

Primary Outcomes

blood markers

Time Frame: 2 years

The expression of CA153, CEA, CA125 in the blood of the patients, which are measured by electro-chemiluminescence immunoassay.

immune inflammation-related protein complexes

Time Frame: 2 years

The change of immune inflammation-related protein complexes which is measured by gel permeation chromatography.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chang Chen

Principal Investigator

Peking Union Medical College Hospital

Study Sites (1)

Loading locations...

Similar Trials